The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition characterized by chronic anovulation and excess ovarian activity. Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit PCOS participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for PCOS prognosis.
Study Type
OBSERVATIONAL
Enrollment
10,000
Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
RECRUITINGLevel of serum FSH (Follicle stimulating hormone)
mIU/mL
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Level of serum LH (Luteinizing hormone)
mIU/mL
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Level of T (Testosterone)
ng/ml
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Body Weight
Recorded in Kilograms
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
Height
Recorded in centimeters
Time frame: From date of inclusion, assessed by each 12 month, up to 40 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.